Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11555026 AHR inhibitors and uses thereof

Patent 11555026 was granted and assigned to Ikena Oncology on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ikena Oncology

Current Assignee

Ikena Oncology

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11555026

Date of Patent

January 17, 2023

Patent Application Number

16890196

Date Filed

June 2, 2020

Patent Citations

‌

US Patent 10570138 Indole AHR inhibitors and uses thereof

‌

US Patent 10689388 Indole AHR inhibitors and uses thereof

‌

US Patent 10696650 AHR inhibitors and uses thereof

Patent Primary Examiner

CPC Code

...

The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11555026 AHR inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API